AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Tryptamine Therapeutics Ltd

0.034

0.000

Volume:- -

Turnover:- -

Market Cap:54.72M

PE:-8.72

High:0.034

Open:0.034

Low:0.034

Close:0.034

52wk High:0.050

52wk Low:0.027

Shares:1.61B

Float Shares:878.05M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.004

EPS(LYR):-0.004

ROE:-92.06%

ROA:-45.59%

PB:9.18

PE(LYR):-8.79

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Tryptamine Therapeutics To Raise A$6.1 Million At A$0.034 Per Share

Tryptamine Therapeutics Ltd-September 2025 Quarterly Activities Report Correction

THOMSON REUTERS

BUZZ-Australia's Tryptamine Therapeutic falls on discounted placement

BRIEF-Tryptamine Therapeutics To Raise A$6.1 Million At A$0.034 Per Share

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TYP.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TYP.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TYP.AU\",,,,,undefined,":{"symbol":"TYP.AU","market":"AU","secType":"STK","nameCN":"Tryptamine Therapeutics Ltd","latestPrice":0.034,"timestamp":1765515600000,"preClose":0.034,"halted":8,"volume":0,"delay":0,"nameEN":"Tryptamine Therapeutics Ltd","floatShares":878046607,"shares":1609510143,"eps":-0.0039,"marketStatus":"Market Closed","change":0,"latestTime":"12-12 16:00:00 AEDT","open":0.034,"high":0.034,"low":0.034,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.0039,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1765753200000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.034,"openAndCloseTimeList":[[1765494000000,1765515600000]],"volumeRatio":0,"lotSize":0,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TYP.AU\",,,,,undefined,":{"symbol":"TYP.AU","floatShares":878046607,"roa":"-45.59%","roe":"-92.06%","lyrEps":-0.003868,"shares":1609510143,"dividePrice":0,"high":0.034,"amplitude":0,"preClose":0.034,"low":0.034,"week52Low":0.027,"pbRate":"9.18","psRate":"34.60","week52High":0.05,"institutionHeld":0,"latestPrice":0.034,"eps":-0.0039,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.0039,"open":0.034},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TYP.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-11-21","symbol":"TYP.AU","oldSymbol":"TYP","defaultRemindTime":1763679600000,"newSymbol":"ENP.AU","exchange":"ASX","type":"symbolChange","dateTimestamp":1763643600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TYP.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TYP.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2584143925","title":"Tryptamine Therapeutics To Raise A$6.1 Million At A$0.034 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2584143925","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584143925?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:33","pubTimestamp":1763570020,"startTime":"0","endTime":"0","summary":"Nov 5 (Reuters) - Tryptamine Therapeutics Ltd ::*TO RAISE A$6.1 MILLION AT A$0.034 PER SHARE*Further company coverage: TYP.AX* ((Reuters.Briefs@thomsonreuters.com;))  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 05-NOV-202501:44:42 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD8jbPxf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TYP.AU","BK7096"],"gpt_icon":0},{"id":"2581216050","title":"Tryptamine Therapeutics Ltd-September 2025 Quarterly Activities Report Correction","url":"https://stock-news.laohu8.com/highlight/detail?id=2581216050","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581216050?lang=en_us&edition=fundamental","pubTime":"2025-11-07 11:32","pubTimestamp":1762486335,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nTUE3DKJGK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TYP.AU","BK7096"],"gpt_icon":0},{"id":"2581718333","title":"BUZZ-Australia's Tryptamine Therapeutic falls on discounted placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2581718333","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581718333?lang=en_us&edition=fundamental","pubTime":"2025-11-05 10:19","pubTimestamp":1762309163,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Tryptamine Therapeutic falls on discounted placement** Tryptamine Therapeutic TYP.AX falls 2.6% to A$0.037; on track for steepest intraday pct decline since October 27** Biotechnology","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nL6N3WH03T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","TYP.AU"],"gpt_icon":0},{"id":"2581797774","title":"BRIEF-Tryptamine Therapeutics To Raise A$6.1 Million At A$0.034 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2581797774","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581797774?lang=en_us&edition=fundamental","pubTime":"2025-11-05 09:44","pubTimestamp":1762307082,"startTime":"0","endTime":"0","summary":"BRIEF-Tryptamine Therapeutics To Raise A$6.1 Million At A$0.034 Per ShareNov 5 (Reuters) - Tryptamine Therapeutics Ltd TYP.AX:TO RAISE A$6.1 MILLION AT A$0.034 PER SHAREFurther company coverage: TYP.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nFWN3WG1TF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","TYP.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/TYP.AU\",params:#limit:6,delay:true,,,undefined,":[]}}